Questions & Verified Answers | Latest Update | Graded A+
1. Which of the following is TRUE regarding KRAS?
Its a membrane GTPase that can activate many proteins in EGFR
signaling pathways such as c-Raf and PI3K
All the above
Aberrant activation of these proteins would usually cause cancer
development independent of upstream EGFR signaling
If KRAS is actively mutated, the inactivation of EGFR by cetuximab or
panitumumab will have no beneficial effect in curing KRAS-induced
cancers
2. Which of the following is most likely the primary reason for Leuprolide
therapy in prostate cancer?
Reduction of serum testosterone levels
Increase in serum estradiol levels
Reduction of serum dihydrotestosterone levels
Reduction of angiogenesis in the prostate gland
Induction of cancer cell apoptosis
3. A 100 kg patient requires chemotherapy, and their actual body weight is used
for dosing. If the same patient loses 20 kg, how should their chemotherapy
dosing be adjusted according to ASCO recommendations?
Adjust the dose based on a fixed percentage of the original weight.
Continue using the original dose regardless of weight change.
, Recalculate the chemotherapy dose based on the new actual body
weight.
Switch to using ideal body weight for dosing.
4. In a clinical trial, a new monoclonal antibody is developed that binds to a
different antigen than existing therapies. What potential advantage might this
provide in cancer treatment?
It will eliminate the need for chemotherapy.
Targeting a different antigen may improve treatment efficacy for
patients with resistance to current therapies.
It will reduce the side effects experienced by all patients.
It will only be effective in early-stage cancers.
5. What is the primary goal of cancer drug treatment?
provide emotional support
to manage symptoms
to destroy cancer cells
prevent spread of cancer
6. What is the primary action of alkylating agents in cancer treatment?
They inhibit hormone production in the body.
They promote the growth of healthy cells.
They attack DNA, causing lethal linkages between DNA strands.
They enhance the immune response against cancer cells.
7. Why is adjuvant therapy given to some breast cancer patients?
, To lower the risk that the cancer will recur
To shrink the tumor
None of the above
To reduce the amount of tissue that needs to be removed during
surgery
8. What do tyrosine kinase inhibitors (TKIs) inhibit in cancer cells?
Phosphate transfer from ATP to tyrosine residues
Protein synthesis
DNA replication
Cell membrane formation
9. What is the primary purpose of hormone therapy in the context of cancer
treatment?
To provide pain relief for cancer patients.
To slow or stop the growth of hormone-sensitive tumors.
To directly kill cancer cells through cytotoxic effects.
To enhance the immune response against cancer cells.
10. A 58-year-old male patient is diagnosed with colorectal cancer. The tumor is
found to be associated with extensive neovascularization. Further
investigation reveals elevated levels of vascular endothelial growth factor
(VEGF). Which of the following best describes the role of VEGF in
neovascularization due to cancer?
VEGF triggers an immune response that leads to regression of
neovascularization.
, VEGF promotes the destruction of blood vessels, inhibiting
neovascularization.
VEGF stimulates the growth of new blood vessels, facilitating
neovascularization.
VEGF acts as a protective barrier, preventing the formation of new
blood vessels.
11. If a new observational study is initiated to track the progression of a specific
type of cancer, what key aspect should researchers focus on to ensure
accurate data collection?
Randomized treatment assignments
Longitudinal tracking of participants
Immediate treatment outcomes
Single-time point assessments
12. What is the primary mechanism by which tyrosine kinase inhibitors (TKIs)
affect cancer cells?
They increase the production of growth factors.
They block signaling by preventing phosphorylation of tyrosine
kinase.
They promote apoptosis in healthy cells.
They enhance the growth of cancer cells.
13. Cancer treatment that uses the patient's own immune system to target
cancer cells for destruction is called
holistic therapy.
immunotherapy.